Quebec man among first in Canada to receive lab-grown cell transplant for Type 1 diabetes
Excerpt from the Press Release:
A 58-year-old Montrealer is the first patient in Quebec to receive a transplant of lab-grown cells to help treat his Type 1 diabetes — a milestone in an international clinical trial underway at the McGill University Health Centre (MUHC).
Bruno Houde, who was diagnosed with the disease at age seven, said life with diabetes has felt like an endless battle.
“It’s a nightmare because you’re fighting something that just always sneaks up on you,” he said. “You never win. You always end up losing.”
People with diabetes, which affects more than 300,000 Canadians, must regularly monitor their blood sugar levels and take insulin daily. Poorly controlled glucose can lead to serious complications, and even death.
Houde says that, thanks to this experimental procedure, his insulin dose dropped by 40 per cent since his transplant in November 2024. His doctors hope the injections could stop altogether as the cells continue maturing inside his body.
Dr. Sara Meltzer, the trial’s co-investigator and an endocrinologist at the MUHC, emphasized that this isn’t a magic fix. The cells continue developing even after infusion, and the patient still has a critical role to play.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?